None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: •Male and female subjectsâ?? in general good health. • Subjects in the age group 18-55 years (both the ages inclusive). • Subjects willing to give a written informed consent and agree to come for a regular follow up visit. • Female and Male Subjects falling under Grade 3 - Grade 8 of hair loss severity grade evaluated as per standard photo numeric 10 point scale • Subjects willing to abide by and comply with the study protocol. • Subjects who have not participated in a similar investigation in the past two weeks. • Subjects complaining of hair fall and damage. • Healthy volunteers with no known allergy as established by medical history. • Subjects who are not on crash dieting. • Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration. • Literate subjects only.
Exclusion criteria
Exclusion criteria: • Subjects who are undergoing hair growth treatment within 3 months before screening into the study. • Subjects having any active scalp disease which may interfere in the study. • Subjects who have treatments of cancer chemotherapy last 6 months before starting study or have a plan to do treatments of them during study terms. • Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania. • Subjects who have had hair transplant. • Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia. • A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. • Subjects on oral medications which will compromise the study. • Subjects who are pregnant or lactating or nursing as established with medical history. • Chronic illness which may influence the cutaneous state. • Subjects participating in other similar cosmetic or therapeutic trial within last two weeks • Subject having history of migraine headache.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ To evaluate the efficacy of Keratex Oil in hair growth in comparison to baseline and control. â?¢ To evaluate the efficacy of Keratex Oil in hair density in comparison to baseline and control.Timepoint: 8 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of Investigational product by assessment of site application reaction by dermatologist and subjects.Timepoint: 8 weeks | — |
Countries
India
Contacts
Dabur India Ltd